FIGURE 2.
Study flow and outcome measurements during 8 wk of the dosing period and 4 wk of the posttreatment observation period. Scoring on the Japan Low Back Pain Evaluation Questionnaire (JLEQ), Japanese Knee Osteoarthritis Measure (JKOM), Japanese Orthopedic Association (JOA), and Brief Pain Inventory (BPI), quality-of-life (QOL) assessment by EuroQOL 5 Dimensions 5-level (EQ-5D-5L), and medical interviews were conducted at baseline and weeks 4 and 8 (dosing period), and week 12 (posttreatment period).